Female Reproductive System Carcinosarcoma

Female Reproductive System Carcinosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 18
Recruiting: 10
Ph III recruiting: 4
Growth YoY: —
Industry share: 6%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05537844	Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma(BriTROC-2)	unknown	—	250	Liz-Anne LewsleyOTHER	1	Sep 23, 2022	clinicaltrials
NCT00954174	Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer	unknown	Phase 3	637	GOG FoundationNETWORK	2	Sep 30, 2021